✦ LIBER ✦

369 Effects of the Specific PI3K Inhibitor BKM120, the Dual PI3K/mTOR Inhibitor BEZ235, and Specific mTOR Inhibitors Everolimus and Temsirolimus in Renal and Hepatic Carcinoma Models Resistant to Sunitinib and Sorafenib

✍ Scribed by Serova, M.; Raballand, A.; Dos Santos, C.; Riveiro, E.; Raymond, E.; Faivre, S.; de Gramont, A.

Book ID: 123463589
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 58 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72167-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of the mTOR inhibitor RAD001, t

Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinoma

✍ Kirstein, Martha M.; Boukouris, Aristeidis E.; Pothiraju, Deepika; Buitrago-Moli 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB

Benchmarking effects of mTOR, PI3K, and

Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib

✍ Serova, Maria; Gramont, Armand; Tijeras-Raballand, AnnemilaÃ¯; Santos, CÃ©lia; R 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 687 KB

1057 ANTI-TUMOR ACTIVITY OF THE mTOR INH

1057 ANTI-TUMOR ACTIVITY OF THE mTOR INHIBITOR RAD001, THE DUAL mTOR/PI3-KINASE INHIBITOR BEZ235 AND THE PI3-KINASE INHIBITOR BKM120 CORRELATES WITH IMPAIRMENT OF OXIDATIVE PHOSPHORYLATION IN HCC

✍ Kirstein, M.M.; Boukouris, A.E.; Pothiraju, D.; Buitrago-Molina, L.E.; Marhenke, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The efficacy of a novel, dual PI3K/mTOR

The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

✍ Niranjan Awasthi; Peter L. Yen; Margaret A. Schwarz; Roderich E. Schwarz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

## Abstract Gemcitabine has limited clinical benefits for pancreatic ductal adenocarcinoma (PDAC). The phosphatidylinositol‐3‐kinase (PI3K)/AKT and mammalian target of rapamycin (mTOR) signaling pathways are frequently dysregulated in PDAC. We investigated the effects of NVP‐BEZ235, a novel dual PI

The dual PI3K/mTOR inhibitor PKI-587 enh

The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models

✍ D'Amato, V; Rosa, R; D'Amato, C; Formisano, L; Marciano, R; Nappi, L; Raimondo, 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 1009 KB

Corrigendum to “Radiosensitization of pr

Corrigendum to “Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions” [Radiother Oncol 106 (2013) 138–146]

✍ Potiron, Vincent A.; Abderrahmani, Rym; Giang, Eric; Chiavassa, Sophie; Di Tomas 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 158 KB